Key result
Review details pharmacological management of acute stroke, post-stroke complications, and secondary prevention for older adults.
Why the study?
Stroke is common in people aged 65 years or older and leads to diverse disabilities and complications requiring optimized pharmacological management.
This narrative review outlines the pharmacological management of acute stroke, its complications, and secondary prevention strategies tailored for older adults.
Supports tailored stroke pharmacotherapy in older adults; leaves open the need for age-specific RCTs before changing practice.
Stroke is one of the most common causes of death and disability. It is more common in people aged 65 years or older. Most patients survive the stroke and live with their disabilities, impacting their quality of life and day‐to‐day function to varying degrees. Stroke sequelae can be associated with a broad range of physical, functional, cognitive, behavioural, emotional and socioeconomic consequences. Optimising the management of stroke and its complications, as well as strategies to prevent stroke recurrence, using both non‐pharmacological and pharmacological approaches, is crucial. This narrative review covers the pharmacological management of acute stroke, common post‐stroke complications and secondary prevention, with a focus on older people.
No takes yet. Share an insight, caveat, or question.
Thomson et al. (2021) conducted a review in Stroke. Pharmacological management was evaluated. This narrative review summarizes the pharmacological management of acute stroke, post-stroke complications, and secondary prevention strategies specifically tailored for older people.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: